Skip to content
Open access · CC-BY via OpenAlex

Proteomics in aging research: A roadmap to clinical, translational research

Ruin Moaddel, Ceereena Ubaida‐Mohien, Toshiko Tanaka, Alexey E. Lyashkov, Nathan Basisty, Birgit Schilling, Richard D. Semba, Claudio Franceschi, Myriam Gorospe, Luigi Ferrucci

Aging Cell · 2021 · ▲ 149 citations

Abstract

The identification of plasma proteins that systematically change with age and, independent of chronological age, predict accelerated decline of health is an expanding area of research. Circulating proteins are ideal translational "omics" since they are final effectors of physiological pathways and because physicians are accustomed to use information of plasma proteins as biomarkers for diagnosis, prognosis, and tracking the effectiveness of treatments. Recent technological advancements, including mass spectrometry (MS)-based proteomics, multiplexed proteomic assay using modified aptamers (SOMAscan), and Proximity Extension Assay (PEA, O-Link), have allowed for the assessment of thousands of proteins in plasma or other biological matrices, which are potentially translatable into new clinical biomarkers and provide new clues about the mechanisms by which aging is associated with health deterioration and functional decline. We carried out a detailed literature search for proteomic studies performed in different matrices (plasma, serum, urine, saliva, tissues) and species using multiple platforms. Herein, we identified 232 proteins that were age-associated across studies. Enrichment analysis of the 232 age-associated proteins revealed metabolic pathways previously connected with biological aging both in animal models and in humans, most remarkably insulin-like growth factor (IGF) signaling, mitogen-activated protein kinases (MAPK), hypoxia-inducible factor 1 (HIF1), cytokine signaling, Forkhead Box O (FOXO) metabolic pathways, folate metabolism, advance glycation end products (AGE), and receptor AGE (RAGE) metabolic pathway. Information on these age-relevant proteins, likely expanded and validated in longitudinal studies and examined in mechanistic studies, will be essential for patient stratification and the development of new treatments aimed at improving health expectancy.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1111/acel.13325
Canonical
link ↗
Fetched
2026-11-13 MST

Cite this

APA
Moaddel, R., Ubaida‐Mohien, C., Tanaka, T., Lyashkov, A.E., Basisty, N., Schilling, B., Semba, R.D., Franceschi, C., Gorospe, M., &amp; Ferrucci, L. (2021). Proteomics in aging research: A roadmap to clinical, translational research. <em>Aging Cell</em>. https://doi.org/10.1111/acel.13325
Vancouver
Moaddel R, Ubaida‐Mohien C, Tanaka T, Lyashkov AE, Basisty N, Schilling B, et al. Proteomics in aging research: A roadmap to clinical, translational research. Aging Cell. 2021. doi:10.1111/acel.13325.
BibTeX
@article{ruin2021Proteo, title = {Proteomics in aging research: A roadmap to clinical, translational research}, author = {Ruin Moaddel and Ceereena Ubaida‐Mohien and Toshiko Tanaka and Alexey E. Lyashkov and Nathan Basisty and Birgit Schilling and Richard D. Semba and Claudio Franceschi and Myriam Gorospe and Luigi Ferrucci}, journal = {Aging Cell}, year = {2021}, doi = {10.1111/acel.13325}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings